Simon Fietz - Dissemin

Language
Login

All papers authored by Simon Fietz

This paper was not found in any repository, but could be made available legally by the author.

2020 Simon Fietz

ORCID

, Romina Zarbl, Dennis Niebel, Christian Posch, Peter Brossart, Gerrit H. Gielen, Sebastian Strieth, Torsten Pietsch, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg, Dimo Dietrich

ORCID

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

Upload

This paper is made freely available by the publisher.

Anne Fröhlich, Judith Sirokay, Simon Fietz

ORCID

, Timo J. Vogt, Jörn Dietrich, Romina Zarbl, Mike Florin, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Lukas Flatz, Sandra S. Ring, Carsten Golletz, Torsten Pietsch and 7 other authors

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Anne Fröhlich, Dennis Niebel, Simon Fietz

ORCID

, Eva Egger, Andrea Buchner, Judith Sirokay, Jennifer Landsberg

ORCID

Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients

Upload

This paper is made freely available by the publisher.

Anne Fröhlich, Sophia Loick, Emma Grace Bawden, Simon Fietz

ORCID

, Jörn Dietrich, Eric Diekmann, Gonzalo Saavedra, Holger Fröhlich, Dennis Niebel, Judith Sirokay, Romina Zarbl, Gerrit H. Gielen

ORCID

, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg and 1 other authors

Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma

Download from doi.org

Missing publications? Search for publications with a matching author name.